Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Sadri M et al. | 2017 | intact cell/cell culture, human umbilical cord mesenchymal stem cells (hUC-MSCs) | static magnetic field | - |
Sakurai H et al. | 1999 | intact cell/cell culture, mouse leukemia cells (P388) and Chinese hamster fibroblast cells (V79) | static magnetic field | 7 T |
Sarvestani AS et al. | 2010 | intact cell/cell culture, bone marrow stem cells (rat) | static magnetic field, co-exposure, also other exposures without EMF | - |
Satari M et al. | 2021 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line) and Huo2 cells (skin fibroblast cells) | static magnetic field, also other exposures without EMF, co-exposure | - |
Schiffer IB et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) and EA 2 (mouse lymphoma cells) | RF field, PW pulsed wave, static magnetic field, low frequency, DC, MRI | 5.8 µT–7.05 T |
Schwenzer NF et al. | 2007 | intact cell/cell culture, Hel 299 (human fibroblast cell line) | static magnetic field, magnetic field, MRI | - |
Sun RG et al. | 2012 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | static magnetic field | 8.8 mT |
Volpe P et al. | 2005 | intact cell/cell culture, Friend erythroleukemia cell line | geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
Wang S et al. | 2022 | intact cell/cell culture, MNNG/HOS, U-2 OS and MG63 (human osteosarcoma cell lines) | static magnetic field, co-exposure, also other exposures without EMF | - |
Wiskirchen J et al. | 1999 | intact cell/cell culture, human fetal lung fibroblasts | static magnetic field, MRI | 1.5 T |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.